Correlation Between Akari Therapeutics and Annexon

Can any of the company-specific risk be diversified away by investing in both Akari Therapeutics and Annexon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akari Therapeutics and Annexon into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Akari Therapeutics PLC and Annexon, you can compare the effects of market volatilities on Akari Therapeutics and Annexon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akari Therapeutics with a short position of Annexon. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akari Therapeutics and Annexon.

Diversification Opportunities for Akari Therapeutics and Annexon

0.16

Correlation Coefficient

Akari Therapeutics  Annexon

Average diversification

The 3 months correlation between Akari and Annexon is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Akari Therapeutics PLC and Annexon in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Annexon and Akari Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akari Therapeutics PLC are associated (or correlated) with Annexon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Annexon has no effect on the direction of Akari Therapeutics i.e., Akari Therapeutics and Annexon go up and down completely randomly.

Pair Corralation between Akari Therapeutics and Annexon

Given the investment horizon of 90 days Akari Therapeutics PLC is expected to generate 1.53 times more return on investment than Annexon. However, Akari Therapeutics is 1.53 times more volatile than Annexon. It trades about 0.09 of its potential returns per unit of risk. Annexon is currently generating about -0.25 per unit of risk. If you would invest  100.00  in Akari Therapeutics PLC on December 28, 2024 and sell it today you would earn a total of  27.00  from holding Akari Therapeutics PLC or generate 27.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Akari Therapeutics PLC  vs.  Annexon

Akari Therapeutics PLC

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Akari Therapeutics PLC are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Akari Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Annexon

Risk-Adjusted Performance

Very Weak

Over the last 90 days Annexon has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Akari Therapeutics and Annexon

The main advantage of trading using opposite Akari Therapeutics and Annexon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akari Therapeutics position performs unexpectedly, Annexon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Annexon will offset losses from the drop in Annexon's long position.

The idea behind Akari Therapeutics PLC and Annexon pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.